The panel examine the problem of bacteria becoming resistant to antibiotics and the threat that this poses to global health security.

4 February 2015


Professor Dame Sally Davies, Chief Medical Officer for England, Department of Health, UK
Professor Kevin Outterson, Associate Fellow, Centre on Global Health Security, Chatham House; Professor of Law, Boston University
Dr Manica Balasegaram, Executive Director, Access Campaign, Médecins Sans Frontières
Dr Nick Cammack, Senior Vice-President and Head, Medicines Development for Diseases of the Developing World, GSK


The speakers consider what actions could be taken by governments, health practitioners and the pharmaceutical sector to restrict the spread of resistant infections. The panellists also reflect on how new economic and business models could help to tackle anti-microbial resistance by encouraging the appropriate use of antibiotics and incentivising innovation in drug development.